Why is Tatva Chintan falling/rising?

As of 19-Sep, Tatva Chintan Pharma Chem Ltd's stock price is rising, currently at 1,106.00, reflecting an increase of 21.0 (1.94%). The stock has shown a positive trend today, outperforming its sector by 2.27% and reversing a two-day decline. It reached an intraday high of Rs 1122.8, which is a 3.48% increase. Over the past week, the stock has gained 8.75%, while its one-year return stands at 14.61%, significantly outperforming the broader market, which has seen negative returns of -0.67%. The company maintains a low debt-to-equity ratio of 0.07, indicating financial stability, which may contribute to investor confidence.
In the broader market context, Tatva Chintan's recent performance contrasts sharply with the BSE500 index, which has generated negative returns of -1.96% over the last year. This suggests that while the overall market has struggled, Tatva Chintan has managed to deliver positive returns, indicating strong company fundamentals. However, it is worth noting that there has been a significant drop in investor participation, with delivery volume falling by 50.5% against the five-day average, which could be a concern for future trading activity. Despite this, the stock remains liquid enough for trading, suggesting that there is still interest among investors.